Find uplifting stories about heroes, innovations, and solutions
21346 results for "** vaccine development"
A major new study of 434 children brings reassuring news for pregnant mothers: getting the COVID-19 mRNA vaccine during pregnancy shows no link to autism or developmental delays. The research tracked children up to 30 months old and found identical outcomes whether mothers received the vaccine or not.
Scientists are fast-tracking three promising vaccines to fight the Ebola outbreak in Congo and Uganda, with clinical trials starting within months. New funding of $62 million is speeding up development of the first vaccines specifically designed for the Bundibugyo virus strain.
After decades of research, scientists have developed a promising vaccine technology against a dangerous intestinal illness that causes millions of severe cases each year. The breakthrough targets a bacterial infection that disproportionately kills children in developing countries.
The scientist who helped create the first COVID-19 vaccine says the hardest part wasn't the research. It was earning trust from people with honest questions about what they were being asked to put in their bodies.
African researchers are racing to develop the continent's first chikungunya vaccine designed specifically for children and local populations. Rwanda is leading a four-year, $17 million partnership across four African nations to test and eventually manufacture the life-saving vaccine.
A new Ebola vaccine developed in just eight weeks has been given to its first human volunteer, with 600,000 doses already manufactured and ready to deploy. The experimental vaccine targets a deadly Ebola strain currently spreading in the Democratic Republic of Congo.
South Africa is preparing to roll out a groundbreaking tuberculosis vaccine for adults that could become the first new TB vaccine in over a century. The M72/AS01E vaccine is currently in Phase 3 trials across five countries and could help eliminate TB as a public health threat by 2030.
An FDA committee greenlighted next year's flu vaccine formulation this week, maintaining the proven update process while vaccine policy debates swirl in Washington. The decision keeps Americans on track for seasonal flu protection.
A Saskatchewan team has developed a groundbreaking vaccine that protects cattle from tuberculosis without interfering with disease testing. If approved, MSX-1 would be the world's first licensed bovine TB vaccine.
Researchers worldwide are developing vaccines that could protect against multiple flu strains for years, ending the need for annual shots. Around a dozen candidates are already in clinical trials.
Scientists just proved that an AI-designed vaccine can trigger a human immune response, marking the first time a computer-created vaccine has worked in people. This breakthrough could revolutionize how we develop vaccines for future diseases.
After decades of neglect, multiple research teams worldwide are finally developing vaccines for hantavirus, with some entering animal trials this summer. What was once considered uncommercial is now gaining momentum, potentially protecting millions in affected regions within years.
The FDA suddenly agreed to review Moderna's revolutionary mRNA flu vaccine after initially rejecting it just a week earlier. Meanwhile, scientists developed an inhaled vaccine that could protect against multiple respiratory illnesses at once.
The same technology that revolutionized COVID vaccines just earned approval for seasonal flu, potentially ending decades of hit-or-miss protection. Moderna's mRNA flu shot marks a new era in how we fight one of America's most common infectious diseases.
Scientists at Stanford Medicine have developed a nasal spray vaccine that protects mice against flu, COVID, allergies, and other respiratory threats for months. If it works in humans, one spray each fall could replace multiple annual shots.
Ghana's parliament just created a special group to make sure every child gets life-saving vaccines, no matter what. The 11-member team will fight to keep vaccine funding steady as the country grows more independent.
Scientists at Johns Hopkins developed a vaccine that may prevent pancreatic cancer before it starts, triggering lasting immune responses in 90% of high-risk patients. None of the 20 participants developed cancer during the study, and some saw their precancerous cysts shrink or disappear.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
Scientists developed a nasal spray vaccine that protected mice from COVID, flu, bacteria, and even allergens for months. Unlike typical vaccines, it activates the body's first-line defense system to fight multiple threats at once.
Abu Dhabi is teaming up with global pharmaceutical company Sanofi to build a cutting-edge Vaccine Innovation Centre powered by artificial intelligence and mRNA technology. The facility will combine research, manufacturing, and pandemic preparedness under one roof to accelerate life-saving vaccine development.
Showing 20 of 21346